Suchergebnisse - "Munakata, Yasuhiko"

PubPharm (52)

1

Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis : a 3-year observational cohort study

enthalten in: Fukushima journal of medical science | 2023

von Miyata, M. | Hirabayashi, Y. | Munakata, Y. | +43

RetractionIn: Fukushima J Med Sci. 2024 Jan 27;70(1):55. - PMID 38267028

2

Pharmacokinetics, pharmacodynamics, and safety of single-dose subcutaneous sarilumab with or without methotrexate in Japanese patients with rheumatoid arthritis : Two single-dose studies

enthalten in: Modern rheumatology | 2023

von Ishii, T. | Sato, Y. | Munakata, Y. | +6

3

Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis : Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III Study

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2019

von van der Heijde, D. | Strand, V. | Tanaka, Y. | +113

4

Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis : A multi-center, prospective cohort study by the Michinoku Tocilizumab Study Group

enthalten in: Modern rheumatology | 2016

von Hirabayashi, Y. | Munakata, Y. | Miyata, M. | +44

5

Discontinuation of etanercept after achievement of sustained remission in patients with rheumatoid arthritis who initially had moderate disease activity-results from the ENCOURAGE study, a prospective, international, multicenter randomized study

enthalten in: Modern rheumatology | 2016

von Yamanaka, H. | Nagaoka, S. | Lee, S. | +20

6

Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy : Results from the 2-year Open-label Extension of the MUSASHI Study

enthalten in: The Journal of rheumatology | 2015

von Ogata, A. | Amano, K. | Dobashi, H. | +78

7

Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate : an open-label extension of a randomized, double-blind, placebo-controlled trial

enthalten in: Modern rheumatology | 2014

von Hara, M. | Ishiguro, N. | Katayama, K. | +108

8

Variable regions of a human anti-DNA antibody O-81 possessing lupus nephritis-associated idiotype

enthalten in: Nucleic acids research | 2013

von Hirabayashi, Y. | Munakata, Y. | Sasaki, T. | +1

9

Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate : a randomized, double-blind, placebo-controlled trial

enthalten in: Modern rheumatology | 2013

von Ishiguro, N. | Yamamoto, K. | Katayama, K. | +108

10

Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate : twelve-month data from a twenty-four-month phase III randomized radiographic study

enthalten in: Arthritis and rheumatism | 2013

von van der Heijde, D. | Tanaka, Y. | Fleischmann, R. | +117

1
2
3
4
5
6
Nächster »
[6]